Cargando…
Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism
Direct-acting oral anticoagulants (DOACs) are prescribed in the treatment of venous thromboembolism, including pulmonary embolism (PE). Evidence is limited regarding the outcomes and optimal timing of DOACs in patients with intermediate- or high-risk PE treated with thrombolysis. We conducted a retr...
Autores principales: | Wolfe, Adam, Phillips, Angela, Tierney, David M, Melamed, Roman, Qadri, Ghazi, Lillyblad, Matthew, Smith, Claire, St. Hill, Catherine, Stenzel, Ashley E, Beddow, David, Kirven, Justin, Kethireddy, Rajesh, Patel, Love |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998410/ https://www.ncbi.nlm.nih.gov/pubmed/36890702 http://dx.doi.org/10.1177/10760296231156414 |
Ejemplares similares
-
Patients’ Plasma Activity of Heparin,
low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips
por: Harenberg, Job, et al.
Publicado: (2022) -
Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration
por: Örd, Lenna, et al.
Publicado: (2022) -
Outcomes in hospitalised patients with sepsis, severe sepsis or septic shock and reported penicillin allergy: a retrospective cohort study
por: Beddow, David, et al.
Publicado: (2022) -
Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis
por: Planer, David, et al.
Publicado: (2023) -
Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021)